ArticleJournal of muscle research and cell motility2000
Genetic analysis of the requirements for alpha-actinin function.
Article in Journal of muscle research and cell motility, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 18 citations in OpenAlex.
- Zasp is required for the assembly of functional integrin adhesion sites.The Journal of cell biology · 2007Article
- Drosophila rolling pebbles colocalises and putatively interacts with alpha-Actinin and the Sls isoform Zormin in the Z-discs of the sarcomere and with Dumbfounded/Kirre, alpha-Actinin and Zormin in the terminal Z-discs.Journal of muscle research and cell motility · 2006Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Null alpha-actinin mutations in Drosophila are lethal and produce conspicuous defects in muscle structure and function. Here, we used transgene rescue to examine the requirements for alpha-actinin function in vivo. First, we tested the ability of a cDNA-based transgene encoding the adult muscle isoform of alpha-actinin under control of the heterologous ubiquitin promoter to rescue the lethality of null alpha-actinin mutations. Successful rescue indicated that alternative splicing, which also generates larval muscle and non-muscle isoforms, was not essential for viability and that there were no strict spatial or temporal requirements for alpha-actinin expression. Secondly, chimeric transgenes, with functional domains of alpha-actinin replaced by similar domains from spectrin, were tested for their ability to rescue alpha-actinin mutants. Replacement of either the actin binding domain or the EF hand calcium binding domain yielded inactive proteins, indicating that these conserved domains were not functionally equivalent. Thirdly, the length of alpha-actinin was modified by adding a 114 amino acid structural repeat from alpha-spectrin to the center of the rod domain of alpha-actinin. Addition of this sequence module was expected to increase the length of the native alpha-actinin molecule by at least 15%. yet was fully compatible with alpha-actinin function as measured by rescued lethality and flight. Thus, unexpectedly, the exact length of alpha-actinin was not critical to its function in the muscle Z disk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.